Anti-Inflammatory Biologics Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The global “Anti-Inflammatory Biologics Market Size” is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019.
Leading Players operating in the Anti-Inflammatory Biologics Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- AbbVie Inc.
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Novartis AG
- UCB S.A.
- Eli Lilly and Company
- Amgen Inc.
- Biogen
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anti-inflammatory-biologics-market-102733
Anti-Inflammatory Biologics Market Analysis 2021:
Increasing Cases of Inflammatory Diseases to Boost Growth in North America
The market in North America stood at USD 28.63 billion in 2019. The growth of the region is attributed to rising government support for the introduction of biosimilars in the region. The potential pipeline candidates along with demand for anti-TNF drugs will aid healthy growth of the market in the region. The increasing prevalence of rheumatoid arthritis will spur demand for the market in North America. The approval of novel drugs will favor growth in Europe in the foreseeable future. For instance, in October 2018, Mylan announced the commercial launch of Hulio, a biosimilar of adalimumab. Asia Pacific is predicted to grow rapidly during the forecast period owing to the growing geriatric population. The increasing preference for biologics for inflammatory diseases will boost the market in Asia Pacific. The Middle East and Africa is likely to rise steadily in the forthcoming years owing to the improving healthcare infrastructure and rising disposable income.
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers & acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733
Detailed Table of Content:
1 Anti-Inflammatory Biologics Market Overview
1.1 Anti-Inflammatory Biologics Product Overview
1.2 Anti-Inflammatory Biologics Market Segment by Type
1.3 Global Anti-Inflammatory Biologics Market Size by Type (2015-2027)
1.3.1 Global Anti-Inflammatory Biologics Market Size Overview by Type (2015-2027)
1.3.2 Global Anti-Inflammatory Biologics Historic Market Size Review by Type (2015-2021)
1.3.2.1 Global Anti-Inflammatory Biologics Sales Market Share Breakdown by Type (2015-2027)
1.3.2.2 Global Anti-Inflammatory Biologics Market Share Breakdown by Type (2015-2027)
1.3.2.3 Global Anti-Inflammatory Biologics Average Selling Price (ASP) by Type (2015-2027)
1.3.3 Global Anti-Inflammatory Biologics Market Size Forecast by Type (2021-2027)
1.3.3.1 Global Anti-Inflammatory Biologics Sales Market Share Breakdown by Application (2021-2027)
1.3.3.2 Global Anti-Inflammatory Biologics Revenue Market Share Breakdown by Application (2021-2027)
1.3.3.3 Global Anti-Inflammatory Biologics Average Selling Price (ASP) by Application (2021-2027)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Anti-Inflammatory Biologics Sales Breakdown by Type (2015-2027)
1.4.2 Europe Anti-Inflammatory Biologics Sales Breakdown by Type (2015-2027)
1.4.3 Asia-Pacific Anti-Inflammatory Biologics Sales Breakdown by Type (2015-2027)
1.4.4 Latin America Anti-Inflammatory Biologics Sales Breakdown by Type (2015-2027)
1.4.5 Middle East and Africa Anti-Inflammatory Biologics Sales Breakdown by Type (2015-2027)
2 Global Anti-Inflammatory Biologics Market Competition by Company
2.1 Global Top Players by Anti-Inflammatory Biologics Sales (2015-2021)
2.2 Global Top Players by Anti-Inflammatory Biologics Revenue (2015-2021)
2.3 Global Top Players Anti-Inflammatory Biologics Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Anti-Inflammatory Biologics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Inflammatory Biologics Market Competitive Situation and Trends
2.5.1 Anti-Inflammatory Biologics Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Anti-Inflammatory Biologics Sales and Revenue in 2019
2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Inflammatory Biologics as of 2019)
2.7 Date of Key Company Enter into Anti-Inflammatory Biologics Market
2.8 Key Company Anti-Inflammatory Biologics Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Anti-Inflammatory Biologics Status and Outlook by Region (2015-2027)
3.1 Global Anti-Inflammatory Biologics Market Size and CAGR by Region: 2015 VS 2021 VS 2027
3.2 Global Anti-Inflammatory Biologics Market Size Market Share by Region (2015-2021)
3.2.1 Global Anti-Inflammatory Biologics Sales Market Share by Region (2015-2021)
3.2.2 Global Anti-Inflammatory Biologics Revenue Market Share by Region (2015-2021)
TOC Continued…!!!
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anti-inflammatory-biologics-market-102733
Anti-Inflammatory Biologics Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
